InvestorsHub Logo

Dreamchaser

08/29/16 9:00 AM

#101857 RE: Dreamchaser #101828

Let's keep our eyes on the prize as MMTC moves forward in this experiment. When successful, watch the stock price fly like a bird.

MIT is also making initial light scattering measurement on a MRSA strains. We purchased two MRSA panels from the American Type Collection that contains 17 different MRSA strains with different sccMec types. It will be interesting to determine if MRSA strains have any consistent light scattering pattern differences compared to methicillin-sensitive S. aureus (MSSA) strains. The mecA gene genomic insertions that confer methicillin resistance are relatively small, between 2.820-2.903 Mb nucleotides and the protein content of the MRSA cell is likely very similar to MSSA strains. It may push the limits of the technology to differentiate MRSA from MSSA. MIT also plans to automate the methods we have generated. Although this system generates an identification for S. aureus faster than traditional methods it is still fairly labor intensive.

Dreamchaser

08/30/16 3:31 PM

#101880 RE: Dreamchaser #101828

The proof is in Hollen's thesis, everyone read it carefully. The MIT-1000 has won fame at North Michigan University. Don't listen to opinions but instead the facts.